Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants

Hyperemia Clinical Trial

Official title:
A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Used Four Times Daily in a Population of Pediatric, Adult, and Geriatric Subjects

Status Completed

Clinical Trial Summary

To compare the safety and tolerability of brimonidine tartrate ophthalmic solution 0.025% versus its vehicle in a population of pediatric, adult, and geriatric participants. At least 51% of participants will be 40 years of age or older.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Hyperemia

Clinical Trial Details

NCT number	NCT01959243
Study type	Interventional
Source	Bausch & Lomb Incorporated
Contact
Status	Completed
Phase	Phase 3
Start date	February 22, 2014
Completion date	June 23, 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02136589` - Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes	Phase 4
Completed	`NCT01959230` - Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness	Phase 3
Recruiting	`NCT05706181` - Heat Therapy, Functional Capacity, and Vascular Health in Older Adults	Phase 1/Phase 2
Completed	`NCT01642147` - Cerebral Blood Perfusion Changes After General Anesthesia for Craniotomy	N/A
Withdrawn	`NCT04132648` - Curcumin and Exercise in Chronic Kidney Disease	Phase 2
Recruiting	`NCT02183779` - PORH and Response to Cold in Raynaud's Phenomenon.	N/A
Completed	`NCT02039765` - Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.	Phase 1
Completed	`NCT00268554` - Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole	N/A